Table of Content - Cancer Biomarkers Market

Global cancer biomarkers market is estimated to be valued at USD 25.60 Bn in 2024 and is expected to exhibit a CAGR of 12.7% during the forecast period (2024-2031).

Cancer biomarkers are biological molecules found in blood, tissues or other body fluids that are sign of a normal or abnormal process, or of a condition or disease. These can be used to detect and monitor cancer or cancer progression. In recent years, cancer biomarkers have gained significant attention from both global public and private organizations as these present minimally invasive ways to diagnose, stage and track cancer. Their use also enables oncologists to personalize treatments based on individual patient’s cancer profiles. Advancements in genetic profiling and high-throughput technologies have unlocked the potential of biomarkers that can predict treatment responses and disease progression more accurately. This has promising implications for improving cancer care globally.

Market Dynamics:

Global cancer biomarkers market growth is driven by rising cancer prevalence worldwide, increasing popularity of precision medicine and companion diagnostics, and growing use of biomarkers in drug development as well as approvals. However, high costs associated with biomarker discovery, validation, and commercialization pose a challenge. Moreover, technical limitations and lack of reimbursements restrain the market growth. The market witnesses lucrative opportunities from emerging economies with large cancer populations and growing health expenditures. Further opportunities lie in discovery of novel biomarkers especially for hard-to-treat cancers through ongoing research efforts.

Key Features of the Study:

This report provides in-depth analysis of the global cancer biomarkers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cancer biomarkers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes bioMérieux Inc., INOVIQ, Bio-Rad Laboratories Inc., Abbott, Becton Dickinson and Company, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., CENTOGENE N.V., PerkinElmer Inc., Siemens Healthineers, F. Hoffmann-la Roche Ltd, Agilent Technologies, Inc, Invitae Corporation, Myriad Genetics, Guardant Health, Illumina, and FOUNDATION MEDICINE, INC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global cancer biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer biomarkers market

Detailed Segmentation-

Biomarker Type:
- CA 125
- HER2
- EGFR
- CD20
- BRAF
- Calcitonin
- Others
Cancer Type:
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Kidney Cancer
- Liver Cancer
- Head & neck Cancer
- Non-small Cell Lung Cancer
- Other Cancers
Profiling Technology:
- OMICS Technology
- Imaging Technology
- Immunoassays
- Cytogenetics
- Others
End User:
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Academic Research Institutes
- Others
Regional:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- bioMérieux Inc.
- INOVIQ
- Bio-Rad Laboratories Inc.
- Abbott
- Becton Dickinson and Company
- Merck KgaA
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- CENTOGENE N.V.
- PerkinElmer Inc.
- Siemens Healthineers
- Hoffmann-la Roche Ltd
- Agilent Technologies, Inc
- Invitae Corporation
- Myriad Genetics
- Guardant Health
- Illumina
- FOUNDATION MEDICINE, INC.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Biomarker Type
  - Market Snapshot, By Cancer Type
  - Market Snapshot, By Profiling Technology
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- PEST Analysis
Global Cancer Biomarkers Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the market
Global Cancer Biomarkers Market, By Biomarker Type, 2019 – 2031, (USD BN)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- CA 125
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- HER2
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- EGFR
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- CD20
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- BRAF
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Calcitonin
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Global Cancer Biomarkers Market, By Cancer Type, 2019 – 2031, (USD BN)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Breast Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Lung Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Prostate Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Kidney Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Liver Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Head & neck Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Non-small Cell Lung Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Other Cancers
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Global Cancer Biomarkers Market, By End User, 2019 – 2031, (USD BN)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- OMICS Technology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Imaging Technology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Immunoassays
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Cytogenetics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Global Cancer Biomarkers Market, By End User, 2019 – 2031, (USD BN)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Hospitals
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Specialty Clinics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Diagnostic Laboratories
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Academic & Research Institutes
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Global Cancer Biomarkers Market, By Region, 2019 – 2031, (USD BN)
- Introduction
  - Market Share Analysis, By Region, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, For Region, 2020–2031
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD BN)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- bioMérieux, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- INOVIQ
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bio-Rad Laboratories, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Abbott
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Becton, Dickinson and Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- QIAGEN
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CENTOGENE N.V.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PerkinElmer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Siemens Healthineers
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- F. Hoffmann-la Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Agilent Technologies, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Invitae Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Myriad Genetics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Guardant Health
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Illumina
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- FOUNDATION MEDICINE, INC.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 27 market data tables and 31 figures on "Global Cancer Biomarkers Market” – Global forecast to 2031

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount